Pro-Dex Cash Flow from Operating Activities 2010-2024 | PDEX

Pro-Dex cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
Pro-Dex Annual Cash Flow Ops
(Millions of US $)
2023 $5
2022 $-1
2021 $-2
2020 $5
2019 $3
2018 $3
2017 $3
2016 $0
2015 $-1
2014 $-0
2013 $-1
2012 $0
2011 $3
2010 $3
2009 $2
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.067B $0.046B
Pro-Dex Inc., with operations in Santa Ana, California, Beaverton, Oregon and Carson City Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Biolase (BIOL) United States $0.005B 0.00